Showing results (21-30 of 34) with videos related to

Sort By:
Pageof 4
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 15, 2026
Spatial Configuration of Pancreatic Cancer Is Associated with Disease Recurrence after Neoadjuvant Therapy and Curative-Intent ResectionLuis H Cisneros, Merih D Toruner, Zafar Siddiqui, et al.
The Journal of Biological Chemistry|January 29, 2020
The extracellular sulfatase SULF2 promotes liver tumorigenesis by stimulating assembly of a promoter-looping GLI1-STAT3 transcriptional complexRyan M Carr, Paola A Romecin Duran, Ezequiel J Tolosa, et al.
The Journal of Biological Chemistry|May 28, 2026
KMT2D depletion promotes KRAS-induced pancreatic carcinogenesis independent of TP53Ezequiel J Tolosa, Glancis L Raja Arul, Ashley N Sigafoos, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]|August 12, 2020
Targeting of the Hedgehog/GLI and mTOR pathways in advanced pancreatic cancer, a phase 1 trial of Vismodegib and Sirolimus combinationRyan M Carr, Narjust Duma, Angela L McCleary-Wheeler, et al.
Annals of Surgical Oncology|March 11, 2025
Molecular KRAS ctDNA Predicts Metastases and Survival in Pancreatic Cancer: A Prospective Cohort StudyJennifer L Leiting, Roberto Alva-Ruiz, Jennifer A Yonkus, et al.
JCI Insight|June 10, 2025
Emerin is an effector of oncogenic KRAS-driven nuclear dynamics in pancreatic cancerLuis F Flores, David L Marks, Renzo E Vera, et al.
Blood|January 28, 2021
Salicylates enhance CRM1 inhibitor antitumor activity by induction of S-phase arrest and impairment of DNA-damage repairJithma P Abeykoon, Xiaosheng Wu, Kevin E Nowakowski, et al.
The Biochemical Journal|August 9, 2020
GLI1/GLI2 functional interplay is required to control Hedgehog/GLI targets gene expressionEzequiel J Tolosa, Maite G Fernandez-Barrena, Eriko Iguchi, et al.
JCO Precision Oncology|July 10, 2026
Long-Term Outcomes and Surgical Conversion After Immunotherapy in Microsatellite Instability-H Biliary Tract CancersPriyanshi Shah, Anina Peersen, Vaibhav Sahai, et al.
Nature Communications|May 19, 2021
RAS mutations drive proliferative chronic myelomonocytic leukemia via a KMT2A-PLK1 axisRyan M Carr, Denis Vorobyev, Terra Lasho, et al.
Pageof 4